enGene Therapeutics Inc. (ENGN) insider trading
enGene Therapeutics Inc. insiders have made 1 open-market purchase worth $10k since Sep 24, 2026, by 1 insider. The latest: William Grossman (CMO) bought $10k, filed Sep 24, 2026, scored 40 out of 100.
Follow ENGN, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Insider purchases
| Filed | Insider | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Sep 24 Form 4 (opens sec.gov) |
William GrossmanCMOCMO · Penny stock: hard to trade | New position | 40 | $10k 5,102 at $1.97 |
— | — |
Insiders who bought ENGN
- William Grossman CMO
Questions
Are insiders buying ENGN stock?
Yes. In the last 90 days, 1 open-market purchase was filed, worth $10k.
Who bought ENGN stock most recently?
William Grossman, CMO, bought 5,102 shares for $10k (Form 4 (opens sec.gov), filed Sep 24, 2026).
How does InsiderBeacon score an insider buy?
Out of 100, from who bought, how much their stake grew, the size of the trade, whether other insiders bought within ten days, where the price sat in its 52-week range, and whether it was a first or a routine buy. The score is fixed when the filing arrives. The formula and the research behind it.
Insiders are also buying, same industry
Data as of Sep 24, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer